BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 37240140)

  • 1. Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes.
    Guo L; Dial S; Shi L; Branham W; Liu J; Fang JL; Green B; Deng H; Kaput J; Ning B
    Drug Metab Dispos; 2011 Mar; 39(3):528-38. PubMed ID: 21149542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA and RNA Sequencing Recapitulated Aberrant Tumor Metabolism in Liver Cancer Cell Lines.
    Sun Y; Tang X; Ye B; Ding K
    J Hepatocell Carcinoma; 2021; 8():823-836. PubMed ID: 34350138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Transcriptomic Analysis of Three Common Liver Cell Lines.
    Arzumanian V; Pyatnitskiy M; Poverennaya E
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principal Component Analysis of Alternative Splicing Profiles Revealed by Long-Read ONT Sequencing in Human Liver Tissue and Hepatocyte-Derived HepG2 and Huh7 Cell Lines.
    Sarygina E; Kozlova A; Deinichenko K; Radko S; Ptitsyn K; Khmeleva S; Kurbatov LK; Spirin P; Prassolov VS; Ilgisonis E; Lisitsa A; Ponomarenko E
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of cisplatin combined with the flavonoid apigenin on HepG2, Hep3B, and Huh7 liver cancer cell lines.
    Papachristou F; Anninou N; Koukoulis G; Paraskakis S; Sertaridou E; Tsalikidis C; Pitiakoudis M; Simopoulos C; Tsaroucha A
    Mutat Res Genet Toxicol Environ Mutagen; 2021 Jun; 866():503352. PubMed ID: 33985696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours.
    Nwosu ZC; Battello N; Rothley M; Piorońska W; Sitek B; Ebert MP; Hofmann U; Sleeman J; Wölfl S; Meyer C; Megger DA; Dooley S
    J Exp Clin Cancer Res; 2018 Sep; 37(1):211. PubMed ID: 30176945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.
    Huang XQ; Zhang XF; Xia JH; Chao J; Pan QZ; Zhao JJ; Zhou ZQ; Chen CL; Tang Y; Weng DS; Zhang JH; Xia JC
    Chin J Cancer; 2017 Sep; 36(1):77. PubMed ID: 28950898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
    Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
    Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Folic Acid in SARS-CoV-2 Infection: An Intriguing Linkage under Investigation.
    Karakousis ND; Gourgoulianis KI; Kotsiou OS
    J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring Dynamic Metabolome of the HepG2 Cell Line: Rise and Fall.
    Kiseleva OI; Kurbatov IY; Arzumanian VA; Ilgisonis EV; Vakhrushev IV; Lupatov AY; Ponomarenko EA; Poverennaya EV
    Cells; 2022 Nov; 11(22):. PubMed ID: 36428976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARγ signaling in hepatocarcinogenesis: Mechanistic insights for cellular reprogramming and therapeutic implications.
    Ishtiaq SM; Arshad MI; Khan JA
    Pharmacol Ther; 2022 Dec; 240():108298. PubMed ID: 36243148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid: a potential inhibitor against SARS-CoV-2 nucleocapsid protein.
    Chen YM; Wei JL; Qin RS; Hou JP; Zang GC; Zhang GY; Chen TT
    Pharm Biol; 2022 Dec; 60(1):862-878. PubMed ID: 35594385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The m6A(m)-independent role of FTO in regulating WNT signaling pathways.
    Kim H; Jang S; Lee YS
    Life Sci Alliance; 2022 May; 5(5):. PubMed ID: 35169043
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.